Growing older has often brought new adventures and challenges to overcome. And by age 65, there are many age related illnesses, one of the most prevalent being pneumonia.
Pneumonia is mainly caused by bacteria, viruses, and other organisms that are breathed into the lungs. People with pneumonia often experience fever, coughing and difficulty breathing.
The medical community says that one of the best ways to protect against pneumonia is to be vaccinated. If an older adult becomes vaccinated at age 65 and then again around 70 he or she are less likely to catch pneumonia. But whether you choose to get vaccinated or not, remember to make healthy decisions for they could make a difference on how well you spend the rest of your life.
Who can be in the study?
Adults 70 years of age and older who are in stable health and who had a dose of the licensed 23-valent pneumococcal polysaccharide vaccine at least 5 years before study enrollment can be in the study. People who have medical conditions that affect the immune system or are taking medications that affect the immune system may not be in the study. There are other conditions and circumstances that may make you ineligible for this study.
Revised: 11/29/14. Copyright © 2006 Clinical Research Associates of Tidewater. All rights reserved.
There are currently two vaccines licensed for use in the United States to prevent pneumococcal infections. One, the 23-valent pneumococcal vaccine, has been available for about 20 years and is used mainly in older adults. It is sometimes called “the pneumonia shot” and is recommended for everyone 65 years of age and older, and for younger adults and children with certain medical conditions. It contains substances to prevent infection with 23 of the pneumococcal strains. One disadvantage of this vaccine is that its effect probably wears off over a period of 5 years.